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Abstract Peroxynitrite (ONOO-)  has recently been implicated 
in connective tissue destruction in vivo. We have studied the 
effect of ONOO-  on the activity of tissue inhibitor of 
metalloprotelnase-1 (TIMP-1) in vitro. The inactivation of 
TIMP-1 by ONOO-  was dose dependent with 50 ~tM ONOO-  
reducing the inhibitory activity of TIMP-1 towards gelatiuase-A 
by 50%. High concentrations of ONOO-  (500 ~tM-5 mM) 
caused protein fragmentation whilst lower concentrations (< 250 
~tM) inactivated TIMP-1 without altering the molecular weight. 
Inactivation could be blocked by ONOO scavengers but not by 
hydroxyl radical scavengers. Our results show that ONOO-  is 
capable of inactivating TIMP-1, a process which could 
potentiate metalloproteinase-mediated issue breakdown. 
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1. Introduction 
Oxidative stress has been implicated in many disease pro- 
cesses including inflammation, reperfusion injury, aging and 
cancer. In inflammation and ischaemic reperfusion significant 
amounts of superoxide (O~-) and nitric oxide (NO') are pro- 
duced [1,2]. Peroxynitrite (ONOO-)  is formed rapidly by the 
interaction between NO" and O~- with a rate constant of 
6.7× 109 M- l . s  -1 in aqueous solution at pH 7.4 [3]. Many 
workers have demonstrated that ONOO-  is an extremely re- 
active species which readily oxidises various biomolecules, 
such as low density lipoprotein [4], DNA [5] and ct-l-protei- 
nase inhibitor [6]. In the latter case, the oxidation of ct-1- 
proteinase inhibitor causes inactivation of its proteinase inhi- 
bitory capacity. ONOO-  can react with the tyrosine residues 
of proteins to form 3-nitrotyrosine [7] and this "marker" mo- 
lecule has been detected at inflammatory sites as well as in 
body fluids [8,9]. Therefore, it has been suggested that 
ONOO-  may contribute to tissue damage. 
Tissue inhibitor of metalloproteinase-1 (TIMP-1) is a mem- 
ber of the naturally-occurring inhibitors of tissue-damaging 
matrix metalloproteinases [10]. It inhibits active metallopro- 
teinases, such as stromelysins, collagenases and gelatinases, by 
forming a tight one-to-one stoichiometric complex [11]. Thus, 
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the balance between the activities of TIMPs and active metal- 
loproteinases is probably a critical factor in the control of 
connective tissue remodelling in both health and disease, 
and a change of this balance in favour of active metallopro- 
teinases may be an important determinant in the disease pro- 
cess. Although the inactivation of TIMPs by either reactive 
oxygen species or proteinases has not been demonstrated in
vivo, the potentiation of metalloproteinase activity through 
inactivation of TIMP-1 by neutrophil elastase has been shown 
in vitro [12]. In this study, we have demonstrated a mechan- 
ism by which oxidative stress might potentiate metalloprotei- 
nase activity by TIMPs inactivation. We report that ONOO-  
is capable of inactivating TIMP-1 effectively. 
2. Materials and methods 
2.1. Human TIMP-1, gelatinase-A and stromelysin-1 
Human recombinant TIMP-1 was expressed and purified from 
C127 cells [13,14]. Human recombinant progelatinase-A [15] and re- 
combinant prostromelysin-1 [ 6] were generously donated by Dr. G. 
Murphy, Strangeways Research Laboratories (Cambridge, UK). Pro- 
gelatinase-A was activated by incubation with 2 mM (4-aminophe- 
nyl)mercuric acetate (APMA) for 1 h at 25°C. Prostromelysin-1 was 
activated by incubating with 2 mM APMA for 4 h at 37°C. The 
conversion of proenzymes to active enzymes was confirmed by SDS- 
PAGE and activity assays. 
2.2. Determination of enzyme activity 
Gelatinase-A was assayed using the synthetic peptide DNP-Pro-Leu- 
Gly-Leu-Trp-Ala-D-Arg-NH2 as described by Stack and Gray [17]. 
The synthetic peptide (26 laM) was cleaved by gelatinase-A (25 nM) 
in 50 mM Tris/100 mM NaC12/10 mM CaC1J0.05% Brij35 (pH 7.4). 
The rate of change in fluorescence of tryptophan (excitation at 280 nm 
with emission at 346 nm) was monitored for a period of 7 min at 37°C. 
The activity of stromelysin-1 was measured using [14C]acetylated 
casein as substrate in 40 mM Tris-HCl (pH 7.6) with 12 mM CaC12 
as described by Cawston et al. [11]. Reaction mixtures were incubated 
for 20 h at 37°C and incorporated 0.93 ~tg/~tl stromelysin. One unit of 
stromelysin activity produced 1 /.tg of casein fragments (soluble in 3% 
(w/v) trichloroacetic acid) in 1 min at 37°C. The specific activity of 
stromelysin after activation by APMA was 739 U/mg. 
2.3. Determination of TIMP-I activity 
TIMP-1 activity was determined by measuring residual enzyme ac- 
tivity after incubating enzymes with TIMP-I for 30 rain (gelatinase-A) 
and 2 h (stromelysin-1) at 25°C. 
2.4. Synthesis of ONOO- 
ONOO was synthesised from 0.2 M NaNO2 and 1 M H202 in 0.5 
M HC1 [18] and stored in 1.5 M KOH at -70°C. Excess H202 in the 
ONOO- solution was removed by MnO2, and the H202 concentra- 
tion was determined by the horseradish peroxidase assay [19]. High 
concentrations of ONOO (>200 mM) were obtained by freeze frac- 
tionation [6]. The concentration of ONOO was determined by its 
absorbance at 302 nm (~302,~m = 1670 M -1 "cm -1) in 1.5 M NaOH. 
2.5. TIMP-1 inactivation by ONOO- 
TIMP-1 (final concentration of 5.5 ktM) was incubated with 
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ONOO (1 p-M, 5 gM, 10 gM, 50 p-M, 100 p-M, 250 [aM, 500 gM, 
1 mM and 5 mM in 375 mM KOH) in 0.1 M phosphate buffer pH 7.0 
(final volume of 100 p-l) for 20 h at 20°C. The final pH of the reaction 
mixture was 8.0. The effect of scavengers on the inactivation of 
TIMP-1 by ONOO- was also examined. For this purpose, mannitol, 
thiourea, benzoate, desferrioxamine, methionine, histidine, lysine, pro- 
line, tyrosine and tryptophan were included in the reaction mixture. 
The molar ratio of scavengers to TIMP-1 was fixed at 182:1. 
2.6. Examination of TIMP-1 molecular form 
SDS-PAGE was carried out in a Tris/glycine buffer system using 
1(~20% gradient gels. Samples were treated in SDS-containing sample 
buffer with or without 2-mercaptoethanol, and bands were revealed 
by silver staining. When a gel was used for Western blotting, proteins 
were detected by Ponceau S (0.03% w/v) prior to incubating with anti- 
TIMP-1 monoclonal antibody (I p-g/ml, Oncogen Science, MA) or 
anti-nitrotyrosine monoclonal antibody (1 p-g/ml, Upstate Biotechnol- 
ogy Inc. NY). 
3. Results 
When human TIMP-1 (5.5 ~tM) was treated with ONOO-  
(1 gM to 1 mM) for 20 h at 20°C, the inhibitory activities of 
T IMP-t  towards both gelatinase-A and stromelysin-1 were 
significantly decreased in a dose-dependent manner (Fig. 1). 
The concentrations of ONOO-  causing 50% inactivation of 
TIMP-1 were approximately 50 gM and 250 gM for gelati- 
nase-A and stromelysin-1, respectively. The difference between 
the dose-response curves generated by the two metallopro- 
teinases was thought to be a result of differing assay meth- 
odologies. 
ONOO-  solutions may contain both nitrate and nitrite 
contamination. In order to examine the effect of these con- 
taminants on TIMP-1 activity, 0.8 mM decomposed ONOO-  
was made by adding ONOO-  to 100 mM potassium phos- 
phate (pH 7.4) at 37°C. There was no remaining ONOO-  in 
solution as determined at 302 nm. When decomposed 
ONOO was incubated with TIMP-1 under conditions iden- 
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Fig. 1. Effect of peroxynitrite (ONOO)  on the ability TIMP-I to 
inhibit gelatinase-A and strnmelysin-1 activities. TIMP-1 (5.5 /aM) 
was exposed to ONOO- (1 gM, 5 gM, 10 gM, 50 gM, 100 /aM, 
250 p-M, 500 gM and 1 mM in 375 mM KOH) in 100 mM phos- 
phate buffer (final pH of solution was 8.0) for 20 h at 20°C. For 
the measurement of gelatinase-A inhibitory activity, 2.5 p-M 
ONOO--treated TIMP-1 was reacted with 2.5 p-M gelatinase-A for 
30 rain at 37°C (-k). For the measurement of stromelysin-1 inhibi- 
tory activity, 2.5 p-M ONOO--treated TIMP-1 was incubated with 
0.15 gM stromelysin-I for 2 h at 37°C (I). After incubating with 
enzymes, the residual enzymic activities were assayed (see section 2). 
The proteinase inhibitory activity of TIMP-1 samples incubated in 
the absence of ONOO- was taken as 100% activity. 
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Fig. 2. Modification of the molecular form of TIMP-1 after treat- 
ment with peroxynitrite (ONOO-). Samples from Fig. 1 experiments 
were examined in parallel by 10-20% gradient SDS PAGE with 
(A) silver staining, and (B) Western blotting with anti-TIMP-1 
monoclonal antibody (1 p-g/ml). Lane: 1, molecular weight markers 
and molecular weight values (kDa) given to the left of gels. Lane 2, 
TIMP-I (5.5 p-M) incubated in the absence of ONOO . Lane 3 to 
11, TIMP-1 (5.5 p.M) incubated in the presence of decreasing con- 
centration of ONOO : lane 3, 5 mM; lane 4, I raM; lane 5, 500 
/aM; lane 6, 250 gM; lane 7, 100 /aM; lane 8, 50 p-M; lane 9, 10 
/aM; lane 10, 5 p-M; and lane 11, 1 /aM. Lane 12, 5.5 /aM TIMP-1 
incubated with 0.8 mM decomposed ONOO-. 
tical to the above dose-response experiments (Fig. 1), it had 
no effect on TIMP-1 as detected using both gelatinase-A and 
stromelysin-1 assays. 
The molecular forms of TIMP-1 after ONOO treatment 
were also examined by SDS-PAGE with silver staining and 
Western blotting with an anti-TIMP-1 monoclonal antibody 
[20]. We used parallel TIMP-1 samples from the activity ex- 
periments (for details see Fig. 1). The human recombinant 
TIMP-1 used in this study is a 28 kDa protein with a trace 
amount of dimer contamination (56 kDa) seen by both silver 
staining and Western-blotting (Fig. 2, Lane 2). Both direct 
protein detection (Fig. 2A) and antibody detection (Fig. 2B) 
showed similar results. High concentrations of ONOO-  
(5 mM and 1 mM) completely degraded TIMP-1 (both the 
28 kDa protein and the 56 kDa dimer) to low molecular 
weight fragments which were not detected by either silver 
staining or anti-TIMP-1 antibody detection. However, using 
500 gM ONOO- ,  TIMP-1 protein bands were seen by both 
protein and antibody staining, but these bands were very 
weak. The intensity of these TIMP-1 bands remained the 
same as the concentration of added ONOO-  was progres- 
sively lowered (250 gM down to 1 gM). Moreover, decom- 
posed ONOO-  did not affect TIMP-1 (Fig. 2, Lane 12). No 
evidence of further polymerisation of TIMP-1 was found by 
either protein or antibody detection. 
Comparing the results of the activity assays (Fig. 1) with 
the SDS-PAGE results (Fig. 2), it appears that protein frag- 
mentation is not directly responsible for TIMP-1 inactivation. 
ONOO-  at a concentration of 250 gM reduced the inhibitory 
activity of TIMP-1 by 80%. However most of this TIMP-1 
was still detected by both protein and antibody detection 
(Lane 6 in Fig. 2). 
TIMP-1 (5.5 p.M) inactivated by various doses of ONOO-  
was also Western blotted and examined by an anti-nitrotyr- 
osine monoclonal antibody [21] to detect nitrosylation of 
TIMP-1 tyrosine residues by ONOO- .  Only TIMP-1 samples 
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exposed to 500 /aM ONOO- showed a single band at the 
28 kDa position (data not shown). The doses tested which 
were higher and lower than 500 gM did not produce nitrotyr- 
osine formation that was detectable by this method. A possi- 
ble explanation for these results is that high concentrations of 
ONOO- (1 and 5 mM) do cause the formation of nitrotyr- 
osine within TIMP-1, but also degrade the protein to frag- 
ments which are not detected on 10-20% SDS-PAGE. Lower 
doses of ONOO- (250 gM or lower) may generate small 
amounts of nitrotyrosine which are not detectable by the cur- 
rent staining method. 
We studied the ability of various scavengers to block the 
inactivation of TIMP-1 by ONOO-. Based on the results of 
the dose-response tudy (Figs. 1 and 2), 500 gM ONOO- was 
chosen to use throughout the course of the scavenger study. 
The legend of Fig. 3 summarises the details of this study. Fig. 
3 demonstrates that thiourea, desferrioxamine, tyrosine and 
tryptophan inhibited TIMP-1 inactivation induced by 500 
laM ONOO- to the extents of 94.2%, 91.1%, 91.8% and 
75.3%, respectively. Methionine offered 50.9% protection 
against ONOO--mediated inactivation. However, mannitol, 
benzoate, lysine, proline and histidine did not provide protec- 
tion against TIMP-1 oxidation by ONOO-. 
4. Discussion 
The balance between the activity of proteinase inhibitors 
and proteinases i  thought o be a critical factor in extracel- 
lular matrix turnover. TIMP-1 is often co-expressed with me- 
talloproteinases from connective tissue cells [22,23]. Okada et 
al demonstrated the proteolytic inactivation of TIMP-1 by 
neutrophil elastase [12] and suggested that neutrophils, which 
infiltrate inflammatory sites, may contribute to TIMP-1 inac- 
tivation. The lack of inhibitory capacity of the natural inhi- 
bitor of neutrophil elastase, ct-l-proteinase inhibitor, at in- 
flammatory sites has been described [24]. 
In the present study, we have demonstrated that ONOO- is 
able to inactivate TIMP-1. The oxidation of TIMP-1 was 
evidenced by blocking with scavengers of reactive oxygen spe- 
cies, such as desferrioxamine and thiourea, and direct detec- 
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Fig. 3. The protective ffect of a range of scavengers and amino 
acids on TIMP-I inactivation by peroxynitrite (ONOO-). Each re- 
action mixture containing TIMP-1 (5.5 gM), ONOO- (500 gM), 
and 1 mM scavenger/amino acid was incubated as detailed in Fig. 
1. The TIMP-1 activity was determined by measuring residual gela- 
tinase-A activity (except tryptophan experiments, in which stromely- 
sin-1 was used). Values are presented as mean+S.D, calculated 
from duplicate runs of three independent experiments (except tryp- 
tophan where two independent experiments were performed). DFO 
represents desferrioxamine. 
tion of 3-nitrotyrosine formation in the TIMP-1 protein. Con- 
centrations of ONOO- as low as 50 /aM inactivated 50% of 
the TIMP-1 as detected by gelatinase-A (Fig. 1) and concen- 
trations over 500 gM readily degraded TIMP-1 protein to 
fragments (Fig. 2). In agreement with our observation of 
TIMP-1 fragmentation, recently Ischiropoulos and A1-Mehda 
have shown that ONOO- can cause partial fragmentation f 
fatty acid-free bovine serum albumin [25]. 
Evidence for the generation of ONOO- in vivo has recently 
been obtained by the detection of nitrotyrosine in inflamma- 
tory sites [9,21] and body fluids [8]. It has been estimated that 
a phagosome in an activated macrophage may generate 
ONOO- at a rate of approximately 500 /aM/min [26]. On 
the other hand, in response to inflammatory cytokines NO" 
levels can be elevated by the induction of inducible nitric 
oxide synthase [27]. Recently, it has been shown that NO" 
can also be generated in ischaemic onditions by direct reduc- 
tion of nitrite to NO" [2]. Thus, production of NO" together 
with O~- during inflammation and ischaemic reperfusion may 
elevate the formation of ONOO-, and subsequent damage to 
biomolecules such as TIMP-1 could occur under these patho- 
logical conditions. 
TIMP-1 inactivation by ONOO- could be blocked by the 
addition of thiourea, tyrosine, desferrioxamine, tryptophan 
and methionine. It is known that thiourea, desferrioxamine, 
and methionine are able to inhibit ONOO--mediated oxida- 
tion [1,6,28,29]. Proline, lysine and histidine were ineffective at 
preventing TIMP-1 inactivation by ONOO- despite the sus- 
ceptibility of histidine to free radical attack [30]. Tyrosine, 
tryptophan and methionine are known to react directly with 
ONOO- [7,25] and these amino acids blocked TIMP-1 inac- 
tivation very effectively. We found that ONOO--mediated 
TIMP-1 oxidation was not blocked by the classic "OH scaven- 
gers, mannitol and benzoate. Similar results with mannitol 
and benzoate have been reported before [6,28]. Inactivation 
of TIMP-1 could only be inhibited by agents which rapidly 
react with ONOO ie tyrosine, tryptophan, methionine, 
thiourea nd desferrioxamine. 
In conclusion, our results suggest hat ONOO- is capable 
of inactivating TIMP-1, a possible mechanism which may 
contribute to the regulation of connective tissue remodelling 
in health and disease. 
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